Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2003-06-27
2010-10-12
Goldberg, Jeanine A (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S023100, C536S024300
Reexamination Certificate
active
07811752
ABSTRACT:
This disclosures provides, in one aspect, a method for detecting non-clinically diagnosed cancer in a patient. In one embodiment, the method includes extracting blood serum or plasma from the patient, and then detecting beta-catenin RNA in the blood serum or plasma. In addition, in this embodiment, the method includes determining the presence of the cancer based on the detected beta-catenin RNA. In another aspect, this disclosure provides another embodiment of a method for detecting non-clinically diagnosed cancer in a patient. In this embodiment, the method includes extracting blood serum or plasma from the patient, and then detecting beta-catenin DNA in the blood serum or plasma. In addition, in this embodiment, the method includes determining the presence of the cancer based on the detected beta-catenin DNA. Related methods for detecting non-clinically diagnosed cancer in a patient comprising detecting beta-catenin-associated gene RNA, and beta-catenin-associated gene DNA, in the blood serum or plasma are also disclosed.
REFERENCES:
patent: 2002/0106685 (2002-08-01), Henning et al.
Wong et al. Clinical Cancer Research, vol. 10, pp. 1613-1617, Mar. 2004.
Osman et al (Clin Cancer, Res. vol. 12, No. 11, pp. 3374-3380, Jun. 2006).
Fleischhacker et al. (Biocheimica et Biophysica Acta, vol. 1775, pp. 181-232, 2007).
Mulcahy et al. Cancer and mutant DNA in blood plasma. The Lancet. Sep. 7, 1996, vol. 348, pp. 28.
Anker et al. Detection of circulating tumour DNA in the blood(plasma/serum) of cancer patients. Cancer and Metastasis Reviews. 1999, vol. 18, pp. 65-73.
Valizadeh et al. Expression of E-cadherin-associate molecules (alpha, beta and gamma-catenins a p 120) in colorectal polyps. Am. J. Pathology. Jun. 1997, vol. 150, No. 6 pp. 1977-1984.
Qin et al. The prognostic molecular markers in hepatocellular carcinoma. World AJ. Gastroenterol. 2002, vol. 8, No. 3, pp. 385-392.
Hsiao Wen-Luan Wendy
Wong Sze-Chuen Cesar
Goldberg Jeanine A
The Hong Kong University of Science and Technology
Wang George G.
Wilkinson & Grist
LandOfFree
Plasma or serum marker and process for detection of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Plasma or serum marker and process for detection of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plasma or serum marker and process for detection of cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4172907